Clinical Trials Directory

Trials / Completed

CompletedNCT00372645

Increasing Folate Status of a General Population(FOLSUPP STUDY)

Effects Of A Mixed Diet Intervention Versus Folic Acid Supplementation And Metafolin® Supplementation On Folate Status And Cardiovascular Disease Risk Factors In Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Quadram Institute Bioscience · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine the best source of folate to raise the folate status of a general population over a 16 week intervention period.

Detailed description

This study is designed to assess whether increasing the consumption of natural food folates from a mixed diet is as effective as supplemental folic acid or supplemental natural folate in raising folate status, reducing biomarkers of cardio vascular disease (CVD) risk, and improving vascular function. Randomised placebo-controlled parallel studies will be undertaken in groups of individuals in Norwich and Sheffield. There will be four treatment arms: a) 200 µg folate per day from folate-rich foods, b) 200 µg folate per day from supplemental folic acid, c) 200 µg folate per day from supplemental Metafolin® (6S 5-methyltetrahydrofolic acid) and d) a placebo group. Results from the two centres will be combined, thus ensuring a wide population is covered. Folate status, biomarkers of CVD risk and vascular function (pulse wave velocity) will be measured before and following the intervention period of 16 weeks, together with possible confounders (such as vitamins B2 \& B12 status, and MTHFR genotype). 7-Day weighed intakes will be used to measure habitual B-vitamin intake during baseline and intervention, to determine changes in folate intake and assist compliance. Additionally, folate content of selected folate-rich foods will be determined for each volunteer. The results will aid the Food Standards Agency (FSA) in formulating public health policy related to improving folate status and reducing CVD risk.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFolic acid (supplement)200 µg folate per day from supplemental folic acid
DIETARY_SUPPLEMENTMetafolin (supplement)200 µg folate per day from supplemental Metafolin®
DRUGPlaceboPlacebo
OTHERFolate rich foods200 µg folate per day from folate-rich foods

Timeline

Start date
2005-05-01
Primary completion
2008-01-01
Completion
2012-01-01
First posted
2006-09-07
Last updated
2015-03-24

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00372645. Inclusion in this directory is not an endorsement.